Levetiracetam is one of the newest anti-epileptic drugs (AEDs), marketed worldwide. Levetiracetam is a first-line treatment in Status Epilepticus in adult patients who are unable to be treated with traditional first-line therapies.
Dossier Available
Levetiracetam IV 5 mg/mL – 10 mg/mL – 15mg/mL solution for infusion (100 mL plastic bags RTU)